about
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseBlood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaRare coding variants in the phospholipase D3 gene confer risk for Alzheimer's diseaseGenome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseExpression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's diseaseGenetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseCommon variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseConcordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's diseaseGene-wide analysis detects two new susceptibility genes for Alzheimer's disease.Views of Caregivers on the Ethics of Assistive Technology Used for Home Surveillance of People Living with Dementia.The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.Survival in dementia and predictors of mortality: a review.The evaluation of a healthcare passport to improve quality of care and communication for people living with dementia (EQuIP): a protocol paper for a qualitative, longitudinal study.Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.Inflammation and anti-inflammatory strategies for Alzheimer's disease--a mini-review.The development of effective biomarkers for Alzheimer's disease: a review.Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease.A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets.Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.BACE1 polymorphisms do not influence platelet membrane beta-secretase activity or genetic susceptibility for Alzheimer's disease in the Northern Irish population.Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease.Cause of death in Alzheimer's disease: a cohort study.Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease.Platelet beta-secretase activity is increased in Alzheimer's disease.Northern Ireland dementia strategy.Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD).No evidence that extended tracts of homozygosity are associated with Alzheimer's disease.Encouraging lifestyle behaviour change in mild cognitive impairment patients: development of appropriate educational material.Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseErratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseAlzheimer's disease and age-related macular degeneration have different genetic models for complement gene variationPrevention of dementia by ACE inhibitors and angiotensin receptor blockers - potential but not provenThe Physical Examination: A Guide for Old Age PsychiatristsElevated Platelet β-Secretase Activity in Mild Cognitive Impairment
P50
Q22251067-DED5CFF8-762F-4A00-9926-0257E326A265Q24240206-42994664-8433-4260-B5F2-FCD024A280FDQ24312938-012E01BB-2EB9-473B-9AD8-026545633827Q24612662-C1EF0BD8-36AF-44D2-8EAD-39EAEE43FBBFQ28278732-96083E47-7657-436C-9F5C-62ACCB9CF9C3Q28748461-38BA5FC5-B335-4F64-B735-D345E775531DQ29614879-B06402E8-DD60-48D1-9804-EDD7675F6DB9Q33526360-C71130E5-95E3-484F-9815-0F8AD4226C7EQ33747916-0BA91922-0A72-4772-A972-74DA4563D0B8Q33840585-F6CD7096-1017-41EB-8688-8C017AA1A83FQ33986970-D809025F-01F0-4882-A116-A7EE9BE9526EQ34335111-4550220A-3F57-441A-829F-AFEAD04AC752Q36099717-95DCF7D4-94BA-4897-83E5-DCC0AA51D9B8Q37031804-38BBD0F6-61F4-4785-94AA-8FDEE283AAA4Q37596821-7CF1CBB3-99F1-4263-A39E-0C4F11F0D3A4Q38016800-ACCB8A70-3F8B-471A-974C-B9988337EA55Q39140766-23DD2FC8-C4F6-4FBD-87CB-CCEBD4D1C897Q39903799-D0AC3D4B-179C-431C-B2D1-9FD1851B2FFEQ43294486-BAC757A6-A61E-47CC-885C-9D97F37055D0Q44110554-5B832922-CF39-4D83-A487-07605744B4FDQ45422099-6BC831CE-4A9F-4D73-9394-2720D5C9AA90Q46324384-333945C4-5C05-4011-A8AE-1489C4C0C8B8Q46434067-4828B327-1D50-4E51-AC91-9EF986425BD0Q48335917-479A8BFE-0EE9-4271-A6D3-DEA5FC9904B3Q51840619-395F9EB4-0AAB-471C-9FE3-619E6FBCAD56Q51847733-F0937568-8B54-4500-B899-B147E2BEFAAAQ51870295-E3C76996-3664-477A-90F4-4DF8377CDBBAQ53321208-DEF88E6C-68BD-4ED3-951B-BE9F20088761Q54792880-D1B7B52F-D318-454A-9E96-AD65FA581431Q56769759-2AAF89B6-F1A7-455F-932F-79EA9FC23283Q56769863-0E0F2447-657D-429A-91E5-3CEBA477511AQ57719174-4F010EE7-0E27-4F12-9F37-1CFBBB74E1EAQ57978643-F6FF7743-AC4F-46C9-A43D-CBF3A544AD43Q57978648-644F7AD6-BEAD-48CA-BABD-8F6857202EDCQ57978683-50627020-2D9B-443A-9925-1E8E5B9F7D6E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen Todd
@ast
Stephen Todd
@en
Stephen Todd
@es
Stephen Todd
@nl
Stephen Todd
@sl
type
label
Stephen Todd
@ast
Stephen Todd
@en
Stephen Todd
@es
Stephen Todd
@nl
Stephen Todd
@sl
prefLabel
Stephen Todd
@ast
Stephen Todd
@en
Stephen Todd
@es
Stephen Todd
@nl
Stephen Todd
@sl
P106
P1153
7102776883
P21
P31
P3835
stephen-todd3
P496
0000-0002-2312-9195